ITMI20010907A0 - Impiego di antagonisti oppioidi per la prevenzione ed il controllo degli effetti collaterali prodotti dagli oppioidi - Google Patents
Impiego di antagonisti oppioidi per la prevenzione ed il controllo degli effetti collaterali prodotti dagli oppioidiInfo
- Publication number
- ITMI20010907A0 ITMI20010907A0 IT2001MI000907A ITMI20010907A ITMI20010907A0 IT MI20010907 A0 ITMI20010907 A0 IT MI20010907A0 IT 2001MI000907 A IT2001MI000907 A IT 2001MI000907A IT MI20010907 A ITMI20010907 A IT MI20010907A IT MI20010907 A0 ITMI20010907 A0 IT MI20010907A0
- Authority
- IT
- Italy
- Prior art keywords
- opioids
- prevention
- control
- side effects
- effects produced
- Prior art date
Links
- 239000003887 narcotic antagonist Substances 0.000 title 1
- 229940005483 opioid analgesics Drugs 0.000 title 1
- 230000002265 prevention Effects 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/167—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction with an outer layer or coating comprising drug; with chemically bound drugs or non-active substances on their surface
- A61K9/1676—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction with an outer layer or coating comprising drug; with chemically bound drugs or non-active substances on their surface having a drug-free core with discrete complete coating layer containing drug
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/485—Morphinan derivatives, e.g. morphine, codeine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4808—Preparations in capsules, e.g. of gelatin, of chocolate characterised by the form of the capsule or the structure of the filling; Capsules containing small tablets; Capsules with outer layer for immediate drug release
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Emergency Medicine (AREA)
- Pain & Pain Management (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Compositions Of Oxide Ceramics (AREA)
- Electrotherapy Devices (AREA)
- Medicinal Preparation (AREA)
Priority Applications (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IT2001MI000907A ITMI20010907A1 (it) | 2001-05-02 | 2001-05-02 | Impiego di antagonisti oppioidi per la prevenzione ed il controllo degli effetti collaterali prodotti dagli oppioidi |
EP02726358A EP1395260A1 (en) | 2001-05-02 | 2002-05-02 | Use of the opioid antagonist naltrexone to prevent and control side effects caused by opioids |
PCT/IB2002/001473 WO2002087582A1 (en) | 2001-05-02 | 2002-05-02 | Use of the opioid antagonist naltrexone to prevent and control side effects caused by opioids |
RU2003135201/15A RU2003135201A (ru) | 2001-05-02 | 2002-05-02 | Применение антагониста опиоидов налтрексона для предупреждения и контроля побочных воздействий, вызванных опиоидами |
ZA200309333A ZA200309333B (en) | 2001-05-02 | 2003-12-01 | Use of the opioid antagonist naltrexone to prevent and control side effects caused by opioids. |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IT2001MI000907A ITMI20010907A1 (it) | 2001-05-02 | 2001-05-02 | Impiego di antagonisti oppioidi per la prevenzione ed il controllo degli effetti collaterali prodotti dagli oppioidi |
Publications (2)
Publication Number | Publication Date |
---|---|
ITMI20010907A0 true ITMI20010907A0 (it) | 2001-05-02 |
ITMI20010907A1 ITMI20010907A1 (it) | 2002-11-02 |
Family
ID=11447580
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IT2001MI000907A ITMI20010907A1 (it) | 2001-05-02 | 2001-05-02 | Impiego di antagonisti oppioidi per la prevenzione ed il controllo degli effetti collaterali prodotti dagli oppioidi |
Country Status (5)
Country | Link |
---|---|
EP (1) | EP1395260A1 (it) |
IT (1) | ITMI20010907A1 (it) |
RU (1) | RU2003135201A (it) |
WO (1) | WO2002087582A1 (it) |
ZA (1) | ZA200309333B (it) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
TWI347201B (en) * | 2003-04-21 | 2011-08-21 | Euro Celtique Sa | Pharmaceutical products,uses thereof and methods for preparing the same |
US20060063792A1 (en) * | 2004-09-17 | 2006-03-23 | Adolor Corporation | Substituted morphinans and methods of their use |
WO2010151741A1 (en) * | 2009-06-25 | 2010-12-29 | Elite Laboratories, Inc. | Abuse resistant oral dosage forms |
US8987289B2 (en) | 2012-12-14 | 2015-03-24 | Trevi Therapeutics, Inc. | Methods for treating pruritus |
US20140179727A1 (en) | 2012-12-14 | 2014-06-26 | Trevi Therapeutics, Inc. | Methods for treating pruritus |
US8637538B1 (en) | 2012-12-14 | 2014-01-28 | Trevi Therapeutics, Inc. | Methods for treatment of pruritis |
EP3826635A4 (en) | 2018-07-23 | 2022-04-27 | Trevi Therapeutics, Inc. | TREATMENT OF CHRONIC COUGH, DIFFICULT BREATHING AND DYSPNEA |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20010006967A1 (en) * | 1992-09-21 | 2001-07-05 | Stanley M. Crain | Method of simultaneously enhancing analgesic potency and attenuating adverse side effects caused by tramadol and other bimodally-acting opioid agonists |
US5580876A (en) * | 1992-09-21 | 1996-12-03 | Albert Einstein College Of Medicine Of Yeshiva University, A Division Of Yeshiva University | Method of simultaneously enhancing analgesic potency and attenuating dependence liability caused by morphine and other bimodally-acting opioid agonists |
US5512578A (en) * | 1992-09-21 | 1996-04-30 | Albert Einstein College Of Medicine Of Yeshiva University, A Division Of Yeshiva University | Method of simultaneously enhancing analgesic potency and attenuating dependence liability caused by exogenous and endogenous opiod agonists |
US6096756A (en) * | 1992-09-21 | 2000-08-01 | Albert Einstein College Of Medicine Of Yeshiva University | Method of simultaneously enhancing analgesic potency and attenuating dependence liability caused by morphine and other bimodally-acting opioid agonists |
CA2314893C (en) * | 1997-12-22 | 2005-09-13 | Euro-Celtique, S.A. | Opioid agonist/antagonist combinations |
AU2001268353A1 (en) * | 2000-06-09 | 2001-12-17 | The Regents Of The University Of California | Method of treating pain using nalbuphine and opioid antagonists |
-
2001
- 2001-05-02 IT IT2001MI000907A patent/ITMI20010907A1/it unknown
-
2002
- 2002-05-02 WO PCT/IB2002/001473 patent/WO2002087582A1/en not_active Application Discontinuation
- 2002-05-02 RU RU2003135201/15A patent/RU2003135201A/ru not_active Application Discontinuation
- 2002-05-02 EP EP02726358A patent/EP1395260A1/en not_active Withdrawn
-
2003
- 2003-12-01 ZA ZA200309333A patent/ZA200309333B/en unknown
Also Published As
Publication number | Publication date |
---|---|
ZA200309333B (en) | 2004-02-17 |
WO2002087582A1 (en) | 2002-11-07 |
ITMI20010907A1 (it) | 2002-11-02 |
RU2003135201A (ru) | 2005-03-27 |
EP1395260A1 (en) | 2004-03-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HK1215171A1 (zh) | 阿片拮抗劑的聚合偶聯物 | |
IL161041A0 (en) | Mch antagonists for the treatment of obesity | |
HK1083505A1 (en) | Ccr5 antagonists useful for treating aids | |
HK1072052A1 (en) | 3-azabicyclo (3.1.0) hexane derivatives as opioid receptor antagonists | |
IL161516A0 (en) | Benzimidazoles useful as protein kinase inhibitors | |
EP1572103A4 (en) | ANTI-ANGIOGENIC USES OF IL-6 ANTAGONISTS | |
EP1399160A4 (en) | NR2B RECEPTOR ANTAGONISTS FOR TREATING OR PREVENTING MIGRAINE | |
MXPA02008402A (es) | Derivados de quinolina como antagonistas alfa-2. | |
IL160060A0 (en) | Piperidine derivatives useful as ccr5 antagonists | |
GB0130261D0 (en) | Lactams as tachykinin antagonists | |
EP1406493A4 (en) | ADMINISTRATION OF MEDIUM BY THE PEPT-2 TRANSPORTER | |
HK1063791A1 (en) | Nk1 antagonists | |
AU2003279841A8 (en) | Uses of human zven antagonists | |
ITMI20010907A0 (it) | Impiego di antagonisti oppioidi per la prevenzione ed il controllo degli effetti collaterali prodotti dagli oppioidi | |
IL157713A0 (en) | Aryl oxime-piperazines useful as ccr5 antagonists | |
AU2003259074A8 (en) | Gal3 antagonists for the treatment of neuropathic pain | |
AU2003223329A8 (en) | Antagonists of rf-amide neuropeptides | |
ITMO20030065A1 (it) | Dispositivo per l'ancoraggio di lastre ceramiche. | |
PL349670A1 (en) | Method of determining the location of protected area transgression place | |
TW482211U (en) | Structure of floor deck | |
ITBS20020073A1 (it) | Dispositivo per il rifornimento di fili singoli o interlacciati | |
TW529342U (en) | Structure of basin seat for pet | |
AU2002317999A1 (en) | Transdermal delivery of 5-ht3 antagonists | |
TW496207U (en) | Improved structure of hanging bracket for spraying device | |
TW523060U (en) | Structure of adjustable door lapping device |